• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清中钒的转运。

On the transport of vanadium in blood serum.

机构信息

Istituto CNR di Chimica Biomolecolare, Trav. La Crucca 3, I-07040 Sassari, Italy.

出版信息

Inorg Chem. 2009 Jul 6;48(13):5747-57. doi: 10.1021/ic802287s.

DOI:10.1021/ic802287s
PMID:19514735
Abstract

The complexation of the VO(2+) ion in several systems that can model the physiological conditions of its transport in blood serum was studied using electron paramagnetic resonance (EPR) spectroscopy. Particularly, the ternary systems formed by (i) VO(2+) and two high-molecular-mass components of blood serum, human serum apo-transferrin (hTf) and human serum albumin (HSA); (ii) VO(2+), hTf, and bL; and (iii) VO(2+), HSA, and bL, where bL is one of the six most important low-molecular-mass bioligands of the blood serum (bL = lactate, citrate, oxalate, phosphate, glycine, or histidine), were examined. The results indicate that, in aqueous solution, transferrin is a stronger binder than albumin, and at the physiological ratio, most of the VO(2+) ion is present as (VO)(2)hTf, and a small amount as (VO)(2)(d)HSA, the dinuclear species formed by albumin where the two metal ions are interacting and the spin state S is 1. Among the bL ligands, only lactate and citrate are able to bind VO(2+) in the presence of transferrin or albumin, the others not interacting at all. Finally, the quaternary systems formed by (i) VO(2+), hTf, HSA, and lactate and (ii) VO(2+), hTf, HSA, and citrate were studied. In these cases, the results suggest that the predominant species is (VO)(2)hTf, followed by the mixed complexes VO(2+)-hTf-lactate or VO(2+)-hTf-citrate, whereas (VO)(2)(d)HSA and (VO)(2)(citrH(-1))(2) are minor components at physiological pH. The conclusions of this study give new insights on how the VO(2+) ion distributes among the blood serum components and is transported in the plasma toward the target sites in the organism.

摘要

使用电子顺磁共振(EPR)光谱研究了 VO(2+)离子在几种可以模拟其在血清中运输的生理条件的体系中的络合作用。特别是研究了由(i)VO(2+)和血液血清中的两种高分子质量成分,人血清脱铁转铁蛋白(hTf)和人血清白蛋白(HSA);(ii)VO(2+)、hTf 和 bL;以及(iii)VO(2+)、HSA 和 bL 形成的三元体系,其中 bL 是血液血清中六种最重要的低分子质量生物配体之一(bL = 乳酸盐、柠檬酸盐、草酸盐、磷酸盐、甘氨酸或组氨酸)。结果表明,在水溶液中,转铁蛋白是比白蛋白更强的配体,在生理比例下,大部分 VO(2+)离子以(VO)(2)hTf 的形式存在,少量以(VO)(2)(d)HSA 的形式存在,这是白蛋白形成的双核物种,其中两个金属离子相互作用,自旋态 S 为 1。在 bL 配体中,只有乳酸盐和柠檬酸盐能够在转铁蛋白或白蛋白存在的情况下与 VO(2+)结合,其他配体根本不相互作用。最后,研究了由(i)VO(2+)、hTf、HSA 和乳酸盐和(ii)VO(2+)、hTf、HSA 和柠檬酸盐形成的四元体系。在这些情况下,结果表明主要物种是(VO)(2)hTf,其次是混合络合物 VO(2+)-hTf-乳酸盐或 VO(2+)-hTf-柠檬酸盐,而(VO)(2)(d)HSA 和 (VO)(2)(citrH(-1))(2) 是生理 pH 值下的次要成分。这项研究的结论提供了关于 VO(2+)离子如何在血清成分之间分配以及在血浆中向生物体中的靶部位运输的新见解。

相似文献

1
On the transport of vanadium in blood serum.血清中钒的转运。
Inorg Chem. 2009 Jul 6;48(13):5747-57. doi: 10.1021/ic802287s.
2
New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum.血清中胰岛素增强型钒化合物生物转化和转运的理解新进展。
Inorg Chem. 2010 Jan 4;49(1):174-87. doi: 10.1021/ic9017213.
3
Interaction of VO2+ ion with human serum transferrin and albumin.VO2+离子与人血清转铁蛋白和白蛋白的相互作用。
J Inorg Biochem. 2009 Apr;103(4):648-55. doi: 10.1016/j.jinorgbio.2009.01.002. Epub 2009 Jan 13.
4
Interaction of VO2+ ion and some insulin-enhancing compounds with immunoglobulin G.VO2+ 离子与一些胰岛素增强化合物与免疫球蛋白 G 的相互作用。
Inorg Chem. 2011 Apr 18;50(8):3717-28. doi: 10.1021/ic200087p. Epub 2011 Mar 24.
5
Speciation of potential anti-diabetic vanadium complexes in real serum samples.实际血清样本中潜在抗糖尿病钒配合物的物种形成
J Inorg Biochem. 2017 Aug;173:52-65. doi: 10.1016/j.jinorgbio.2017.04.023. Epub 2017 Apr 25.
6
Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies.黄酮类配体形成的潜在抗肿瘤V(IV)O配合物的行为。2. 槲皮素和桑色素磺酸盐衍生物的表征、与血浆生物配体的相互作用及初步生物转化研究。
J Inorg Biochem. 2015 Dec;153:167-177. doi: 10.1016/j.jinorgbio.2015.07.018. Epub 2015 Jul 31.
7
New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.血清蛋白与双(麦芽醇)氧钒(IV)相互作用的新见解:胰岛素增强型钒药物的转运与生物转化
J Am Chem Soc. 2005 Apr 13;127(14):5104-15. doi: 10.1021/ja043944n.
8
Transport of the anti-diabetic VO2+ complexes formed by pyrone derivatives in the blood serum.在血清中运输由吡喃酮衍生物形成的抗糖尿病 VO2+ 配合物。
J Inorg Biochem. 2012 Oct;115:87-99. doi: 10.1016/j.jinorgbio.2012.04.020. Epub 2012 May 11.
9
VO complexes with antibacterial quinolone ligands and their interaction with serum proteins.含有抗菌喹诺酮配体的 VO 复合物及其与血清蛋白的相互作用。
Dalton Trans. 2018 Feb 13;47(7):2164-2182. doi: 10.1039/c7dt04216g.
10
Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-chelated species and biological implications.在高配体与金属摩尔比的水溶液中,由柠檬酸盐和酒石酸盐形成的氧钒(IV)配合物的电位、光谱、电化学和密度泛函理论表征:双螯合物中三角双锥畸变的影响及生物学意义
Dalton Trans. 2008 Sep 28(36):4903-16. doi: 10.1039/b803520b. Epub 2008 Jul 30.

引用本文的文献

1
Vanadium Compounds with Antidiabetic Potential.具有抗糖尿病潜力的钒化合物。
Int J Mol Sci. 2023 Oct 27;24(21):15675. doi: 10.3390/ijms242115675.
2
Identification of Potential Artefacts in In Vitro Measurement of Vanadium-Induced Reactive Oxygen Species (ROS) Production.鉴定体外测量钒诱导活性氧(ROS)产生中的潜在假象。
Int J Environ Res Public Health. 2022 Nov 18;19(22):15214. doi: 10.3390/ijerph192215214.
3
The Effects of Chromium and Vanadium on Biomarkers of Carbohydrate and Lipid Metabolism in Workers Exposed to Coal Fly Ash.
铬和钒对接触煤粉煤灰工人碳水化合物和脂质代谢生物标志物的影响
J Xenobiot. 2022 Oct 19;12(4):307-316. doi: 10.3390/jox12040021.
4
Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme.具有药理活性的双(麦芽酚)氧钒(IV)与溶菌酶的多重和可变结合。
Inorg Chem. 2022 Oct 17;61(41):16458-16467. doi: 10.1021/acs.inorgchem.2c02690. Epub 2022 Oct 7.
5
Comparison of the Effects on Bovine Serum Albumin Induced by Different Forms of Vanadium.不同形式钒对牛血清白蛋白作用的比较
Biol Trace Elem Res. 2023 Jun;201(6):3088-3098. doi: 10.1007/s12011-022-03373-6. Epub 2022 Aug 1.
6
Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections.不稳定金属配合物的有利反应性:基于金属的抗癌药物用于瘤内注射的潜在应用。
Pharmaceutics. 2022 Apr 4;14(4):790. doi: 10.3390/pharmaceutics14040790.
7
Internal dose of vanadium in rats following repeated exposure to vanadyl sulfate and sodium orthovanadate via drinking water.大鼠经饮水摄入硫酸氧钒和正钒酸钠后体内钒的剂量。
Toxicol Appl Pharmacol. 2021 Feb 1;412:115395. doi: 10.1016/j.taap.2021.115395. Epub 2021 Jan 6.
8
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins.潜在氧化钒(IV)药物和阿玛瓦丁与模型蛋白质相互作用的电喷雾电离质谱研究。
Inorg Chem. 2020 Jul 20;59(14):9739-9755. doi: 10.1021/acs.inorgchem.0c00969. Epub 2020 Jun 25.
9
Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.钒:综合其药理毒理机制和多方面应用的全面概述,以及对进一步研究趋势的总结,探讨其风险和可能的益处。
J Trace Elem Med Biol. 2020 Sep;61:126508. doi: 10.1016/j.jtemb.2020.126508. Epub 2020 Apr 12.
10
Vanadium: History, chemistry, interactions with α-amino acids and potential therapeutic applications.钒:历史、化学性质、与α-氨基酸的相互作用及潜在治疗应用
Coord Chem Rev. 2018 Oct 1;372:117-140. doi: 10.1016/j.ccr.2018.06.002. Epub 2018 Jun 21.